← FDA DRUG APPROVALS
FDA ANDA · ANDA211694
PYRIDOSTIGMINE
pyridostigmine bromide oral
Sponsor: NOVITIUM PHARMA
APPLICATION
ANDA211694
TYPE
ANDA
ORIGINAL APPROVAL
2019-03-08
LATEST ACTION
2019-03-08
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Prescription
Products
PYRIDOSTIGMINE BROMIDEPrescription
PYRIDOSTIGMINE BROMIDE 60MG/5ML · SYRUP · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.